Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session

Published 08/09/2022, 17:15
Updated 08/09/2022, 18:11
© Reuters.  Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session

Gainers

  • ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
  • Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) surged 64% to $29.35 after the FDA Advisory Committee voted that available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS. Citigroup (NYSE:C) and SVB Leerink raised their price targets.
  • Benitec Biopharma Inc. (NASDAQ: BNTC) shares rose 58% to $0.9346. The company, last week, filed its annual report on Form 10-K for the quarter ended June 30, 2022, with the U.S. Securities and Exchange Commission.
  • Rubius Therapeutics, Inc. (NASDAQ: RUBY) rose 39.4% to $1.21 after declining 11% on Wednesday. Rubius Therapeutics, last month, posted a Q2 loss of $0.49 per share.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) gained 22.2% to $0.2733.
  • Nutex Health, Inc. (NASDAQ: NUTX) gained 21.5% to $3.85. Nutex Health recently posted a Q2 loss of $0.03 per share.
  • Asana, Inc. (NYSE: ASAN) shares gained 21% to $23.03 after the company reported better-than-expected results for its second quarter and issued a strong sales guidance. RBC Capital and Citigroup raised their price targets on the stock.
  • Relay Therapeutics, Inc. (NASDAQ: RLAY) surged 19.9% to $30.40. Relay Therapeutics announced efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients with a FGFR2-fusion or rearrangement FGFR inhibitor-naïve cholangiocarcinoma: ReFocus trial.
  • Allego N.V. (NYSE: ALLG) gained 17.6% to $4.63. Allego recently announced first half financial results and 2022 revenue expectations.
  • LifeStance Health Group, Inc. (NASDAQ: LFST) rose 17.6% to $8.95. LifeStance Health named Ken Burdick as CEO and Chairman.
  • Terns Pharmaceuticals, Inc. (NASDAQ: TERN) jumped 15.8% to $4.40.
  • AeroVironment, Inc. (NASDAQ: AVAV) gained 15.3% to $102.20 after reporting upbeat quarterly sales.
  • Eve Holding, Inc. (NYSE: EVEX) rose 14.8% to $7.07. United reported a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
  • Cazoo Group Ltd (NYSE: CZOO) surged 14.7% to $0.70. The company announced it will wind down operations in mainland Europe to focus on core UK market
  • Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) rose 14.6% to $23.90. Rhythm Pharmaceuticals announced new employment inducement grants. Goldman Sachs (NYSE:GS) maintained Rhythm Pharmaceuticals with a Buy and raised the price target from $28 to $31.
  • Forge Global Holdings, Inc. (NYSE: FRGE) rose 14.4% to $4.45.
  • Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) gained 14.1% to $680.56 after the company announced that the primary endpoints were met in two pivotal trials investigating novel aflibercept 8 mg with 12- and 16-week dosing regimens in patients with diabetic macular edema and wet age-related macular degeneration.
  • Phreesia, Inc. (NYSE: PHR) rose 13.6% to $27.19 after the company reported better-than-expected Q2 sales results and raised the low-end of its FY23 sales guidance.
  • Intapp, Inc. (NASDAQ: INTA) gained 12.4% to $16.52 after the company reported better-than-expected Q4 results and issued guidance above estimates.
  • First High-School Education Group Co., Ltd. (NYSE: FHS) rose 11.4% to $0.7150.
  • Albireo Pharma, Inc. (NASDAQ: ALBO) surged 11% to $18.50. Guggenheim initiated coverage on Albireo Pharma with a Buy rating and announced a price target of $55.
  • Mullen Automotive, Inc. (NASDAQ: MULN) gained 10.7% to $0.7449 after the company announced it has acquired a 60% controlling interest in Bollinger Motors for $148.2 million in cash and stock.
  • Lyft , Inc. (NASDAQ: NASDAQ:LYFT) gained 10.5% to $16.25 amid vague rumors from a questionable source mentioning the company.
  • Revance Therapeutics, Inc. (NASDAQ: RVNC) rose 9.4% to $22.78 after the company announced FDA approval of DAXXIFY for injection for temporary improvement of moderate to severe frown lines.
  • Snap Inc . (NYSE: NYSE:SNAP) rose 7.3% to $12.29 on continued strength after a recent internal memo obtained by The Verge suggested the company is aiming to reach $6 billion in revenue and 450 million users by next year.
  • Heliogen, Inc. (NYSE: HLGN) rose 7% to $2.3650.
  • GameStop Corp . (NYSE: NYSE:GME) rose 7% to $25.72 after the company reported better-than-expected earnings for its second quarter and also announced a partnership with cryptocurrency exchange FTX to bring more customers to the digital asset space.
  • Zillow Group, Inc. (NASDAQ: ZG) gained 6.9% to $37.80 after Jefferies maintained a Buy rating on the stock and raised its price target from $48 to $50.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • Great Panther Mining Limited (NYSE: GPL) shares dropped 21.4% to $0.2542. The company recently announced it has determined to file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act, which will provide credit protection.
  • Troika Media Group, Inc. (NASDAQ: TRKA) fell 18.3% to $0.5310 after declining around 6% on Wednesday.
  • Erasca, Inc. (NASDAQ: ERAS) declined 18.1% to $7.70. Erasca announced preliminary Phase 1/1b monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in BRAF-driven and RAS/MAPK-altered solid tumors.
  • PlayAGS, Inc. (NYSE: AGS) shares fell 17.4% to $6.29.
  • Biophytis S.A. (NASDAQ: BPTS) declined 16.2% to $0.9301. Biophytis recently announced top-line results from its phase 2-3 COVA clinical study evaluating Sarconeos in the treatment of COVID-19-related respiratory failure.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) declined 15.8% to $0.3475.
  • Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) dipped 15.2% to $1.68.
  • Bilibili Inc. (NASDAQ: BILI) fell 13.8% to $20.37 following Q2 results.
  • Tandy Leather Factory Inc. (NASDAQ: TLF) fell 13% to $5.35 following uplisting of its stock.
  • Graphex Group Limited (NASDAQ: GRFX) dropped 12.7% to $1.64. The company recently provided a business update and highlighted 2022 milestones.
  • MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) fell 12.3% to $20.84. The company posted upbeat quarterly earnings, but issued weak FY23 forecast. MasterCraft Boat also sold its NauticStar business to Iconic Marine Group.
  • Mercer International Inc. (NASDAQ: MERC) dipped 10.8% to $14.32.
  • Genenta Science S.p.A. (NASDAQ: GNTA) fell 10.7% to $4.75.
  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares fell 10.6% to $0.56. Chembio Diagnostics filed for potential stock offering.
  • Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) dropped 10.2% to $39.47. While the company reported better-than-expected Q2 results, operating income dropped from 2021 levels.
  • Skillsoft Corp. (NYSE: SKIL) fell 10% to $2.42 after the company posted downbeat quarterly sales and authorized a $30 million share buyback.
  • The Lovesac Company (NASDAQ: LOVE) dropped 8.3% to $27.40 following Q2 results.
  • HyreCar Inc. (NASDAQ: HYRE) fell 8.2% to $1.2575. HyreCar shares gained around 8% on Wednesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
  • American Eagle Outfitters , Inc. (NYSE: NYSE:AEO) shares fell 7.8% to $10.68 after the company reported worse-than-expected Q2 EPS results.
  • McCormick (NYSE:MKC) & Company, Incorporated (NYSE: MKC) fell 7.7% to $78.47. McCormick said it expects third-quarter FY22 sales to increase about 3% year-on-year and 6% in constant currency.
  • Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) fell 7.5% to $18.31 after the company priced its common stock offering of about 5.71 million shares at $17.50 per share.
  • Wayfair Inc. (NYSE: W) fell 6.3% to $47.50 after the company reported a proposed offering of $600 million convertible senior notes.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.